SBIR/STTR Research Award

Development of a Low-Profile Dual Hormone Patch Pump with Novel Occlusion Sensor

Award identifier 2a4a7357b5c660f8f3efb5436aaa6fb9852579d0fbe1908fe91be964e1a84cbbAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,397,527

Program and phase

SBIR · Phase II

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
SFC FLUIDICS, INC.
Proposal award date
2018-09-20
Contract end date
2020-08-31
UEI
GTPCCLD8LK26
Solicitation number
PA17-302
Topic code
200

Research abstract

Development of a Low Profile Dual Hormone Patch Pumpwith Novel Occlusion Sensor Project SummaryThe Specific Aim of this project is to develop a discretelow profiledual hormone drug delivery system using SFC Fluidicsenabling microfluidic technologiesA DualPumpwill be developed in which one proprietary ePumpbody will independently and accurately deliver both insulin and glucagon from two separate reservoirsLatching safety valve sets will independently and safely control the delivery of each hormone and a dispense confirmation sensor will notify the user of any dosing errors resulting from occlusions or electrical mechanical failuresPhase II will see the integration of all components into an accuratediscretelow profile wearable podextensive benchtop testing and initial testing in swineThe end goal of Phase II is production of a DualPump module that has been introduced to the FDA and is ready to be integrated with all other components required for a dual hormone artificial pancreasDuring Phase IIBSFC Fluidics will work with manufacturers of continuous glucose monitorscontrol algorithms and stable drug formulations to develop an FDA approvedrobustand reliable dual hormone artificial pancreas Project NarrativeThe proposed DualPump APTM system will improve glycemic control as compared to an insulin only Artificial Pancreas by providing the ability to correct a hypoglycemic conditionThe DualPump AP will have the necessary safety features and low dose precision to meet the need for insulin and glucagon delivery for people with Typediabetesespecially childrenadolescentsand individuals that are hypoglycemic unaware

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

17 SBIR/STTR records share this UEI (2004–2023). Reported award amounts total $9,636,875. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: National Science Foundation, Department of Health and Human Services, Department of Defense, National Aeronautics and Space Administration

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.